SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Strategies & Market Trends : TATRADER GIZZARD STUDY--Stocks 12.00 or Less.....

 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: TATRADER who wrote (3454)10/1/1998 2:42:00 PM
From: majormember  Read Replies (1) of 59879
 
OSTE rating lowered, bad day to do it, but come Nov things
may look better....bought Nov AMZN 75 puts...Skane
~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~

" NEW YORK, Oct 1 (Reuters) - Osteotech Inc
(NASDAQ:OSTE) said
its shares tumbled Thursday after BancBoston Robertson Stephens
downgraded the company on concerns its third quarter revenues
would fall short of expectations.
Robertson Stephens analyst Wade King lowered his rating on
Osteotech to buy from strong buy, citing "seasonal summer
softness and a scheduled plant shutdown" during the third
quarter.
King trimmed his third quarter revenue estimate to $14.4
million from $15.5 million. But he stuck to his forecast that
Osteotech would deliver diluted per share earnings of $0.26 in
the third quarter -- 44 percent higher than the 1997 quarter.
Osteotech, an Eatontown, N.J., company which manufactures
orthopedic and surgical products, was off 5-15/16 to 20-9/16 in
afternoon trade.
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext